Back on April 21st NFTRH 548 noted that the medical device babies were getting thrown out with the politically hyped bathwater that was submerging the

Back on April 21st NFTRH 548 noted that the medical device babies were getting thrown out with the politically hyped bathwater that was submerging the
On May 22 this post reviewed… What Healthcare Needs to Do to Go Bullish In that post we reviewed the XLV/SPY ratio, noting the hard
It’s been a hard road for this more defensive sector since the casino bottomed out at the Christmas Eve Massacre and its patrons gradually regained
We have been noting that Tech, for example, is 100% intact to its daily, weekly and monthly up trends. As I hold a big chunk
Semi Sector Let’s begin at the beginning, with our Semi Equipment indicators. Again, for the many folks who were not with us in January of
The Healthcare sector, under pains of congressional follies in trying to hammer out anything in revision to Obamacare, is not responding well. Since our last
A look at the general Healthcare ETF (XLV), which includes BioPharma, Devices/Equipment and Services shows it easing below the trend line. IHI is at lateral
Back in April of this year we did an NFTRH+ on BioPharma ABBV and its amazingly similar setup to 2016’s NFTRH+ pick, LRCX. The original
There was the high, tight one on Biotech iShares, IBB and then others noted on the Medical Device iShares, IHI and the general sector SPDR,
We noted the high, tight one on IBB yesterday and today it and its bros in the Healthcare sector appear to want to break these
Less than 3 bucks from target #1 (75), I am taking the profit here. ABBV is very overbought as it led the momentum that recently
In line with our bullish forward view on USD, behold the very bearish state of the Commercial Hedger positions in the Euro (courtesy of Sentimentrader).
The Healthcare SPDR, XLV is going up, joining the early moving IHI (like Semi in early 2016, I’ve felt like a lone voice extolling Medical
I made a rather bemused post on January 11 as Donald Trump said the word “Pharma” in his first formal post-election press conference and man,